New DNA Tech: Creating Unicorns and Curing Cancer for Real?
By David Ewing Duncan,
The Daily Beast
| 03. 30. 2015
Untitled Document
“We have within our grasp the technology to change evolution. This could change the course of biological life.”
— Paul Berg, Nobel Laureate and a pioneer of genetic engineering
In 2012, scientists in the U.S. and Sweden invented a technology as potentially life-altering as splitting the atom. One that you haven’t heard of—yet—called “CRISPR-Cas9”. This innovation with the cumbrous name allows biologists to edit DNA almost as easily as cutting and pasting words and letters on a laptop.
Scientists say that CRISPR-Cas9 may soon allow them to perform miraculous fixes to eliminate or alter mutations that cause everything from some cancers to Parkinson’s disease. More whimsically, the technology could be used to create, say, a unicorn, or a pig with wings; though it’s unlikely they could make swine fly. More nefariously, terrorists or the military might create pathogens that could harm far more people than splitting the atom has so far. Or, an accident could occur unintentionally.
The question is how to turn this seemingly earth-shattering technology from a yawn in the public perception into a topic that...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...